新西兰药物危害排名研究:一个多标准决策分析
Rose Crossin1, Lana Cleland1,2, Chris Wilkins3
1Department of Population Health, University of Otago, Christchurch, New Zealand.
Journal of psychopharmacology (Oxford, England)
|June 24, 2023
概括
这项研究使用多标准决策分析 (MCDA) 对新西兰的精神活性药物危害进行了排名. 酒精,甲基胺和合成大麻素被发现是对一般人口和年轻人最有害的药物.
科学领域:
- 公共卫生 公共卫生
- 药理学 药理学是指药理学的学科.
- 药物成科学 药物成科学
背景情况:
- 精神活性药物使用带来了复杂的危害,需要特定的环境减少危害策略.
- 评估毒品危害需要了解有关人口的具体特征.
- 对药物危害的全面评估对于有效的公共卫生干预至关重要.
研究的目的:
- 为了评估和排名的精神活性药物危害在奥特罗亚新西兰.
- 应用多标准决策分析 (MCDA) 框架进行毒品危害评估.
- 区分和分析毒品对总人口和青少年 (12-17岁) 的危害.
主要方法:
- 在辅助研讨会中利用两组专家小组对毒品危害进行排名.
- 对总人口和青少年的17个危害标准得分为23种药物.
- 采用了一个摇摆权重过程和专门的MCDA软件进行分析.
主要成果:
- 酒精,甲基胺和合成大麻素被确定为对总人口和年轻人最有害的.
- 烟草是对总人口有害的第四大毒品.
- 酒精是总人口伤害的主要原因,考虑自我伤害和伤害他人.
结论:
- 该研究提供了关于新西兰奥特亚罗亚精神活性药物危害的详细,具体的背景见解.
- 调查结果强调了考虑特定于国家和特定于人口子组的毒品危害的重要性.
- 结果强调了多标准决策分析的价值,以告知减少危害的战略.
相关概念视频
Drug Regulation
1.4K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.4K
Drug Control Governance: Regulatory Bodies and Their Impact
191
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
191
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
148
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
148
Combined Effects of Drugs: Antagonism
8.7K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
8.7K
Hazard Ratio
166
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
166
Pharmacovigilance
908
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
908


